SI BONE Inc (SIBN) Actualités

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

SANTA CLARA, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device...

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device...

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

SANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 4 - Statement of changes in beneficial ownership of securities